Pooled analyses showed that PECAM-1 concentrations were significantly higher in SSc patients compared to controls (SMD=1.65, 95% CI 0.33 to 2.98, p=0.014; I2 = 89.0%, p=0.003; Figure 4). This evidence concerns the gene PECAM1 and systemic sclerosis.